In vitro and in vivo activity of first generation cephalosporins against Leptospira

American Journal of Tropical Medicine and Hygiene

Volumn 85, Issue 5, 2011, Pages 905-908

  Harris, Brande M ^a   Blatz, Peter J ^b   Hinkle, Mary K ^b   McCall, Suzanne ^b   Beckius, Miriam L ^b   Mende, Katrin ^b,c   Robertson, Janelle L ^d   Griffith, Matthew E ^b   Murray, Clinton K ^b   Hospenthal, Duane R ^b  

^a WILFORD HALL MEDICAL CENTER   (United States)

^b BROOKE ARMY MEDICAL CENTER   (United States)

^c UNIFORMED SERVICES UNIVERSITY OF THE HEALTH SCIENCES   (United States)

^d Elgin Hospital   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CEFALEXIN; CEFAZOLIN; CEFDINIR; CEFEPIME; CEFOTAXIME; CEFOXITIN; CEFTAROLINE; CEFTRIAXONE; CEPHALOSPORIN DERIVATIVE; DOXYCYCLINE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIBIOTIC SENSITIVITY; ARTICLE; BROTH DILUTION; CONTROLLED STUDY; FEMALE; IN VITRO STUDY; IN VIVO STUDY; LEPTOSPIRA; LEPTOSPIROSIS; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; SEROTYPE; SURVIVAL;

ANIMALS; ANTI-BACTERIAL AGENTS; CEPHALOSPORINS; CRICETINAE; DOXYCYCLINE; DRUG RESISTANCE, BACTERIAL; FEMALE; LEPTOSPIRA; LEPTOSPIROSIS; MESOCRICETUS; MICROBIAL SENSITIVITY TESTS;

CRICETINAE; LEPTOSPIRA;

EID: 81155131383     PISSN: 00029637     EISSN: None     Source Type: Journal    
DOI: 10.4269/ajtmh.2011.11-0352     Document Type: Article

References (22)

1. Bharti AR, Nally JE, Ricaldi JN, Matthias MA, Diaz MM, Lovett MA, Levett PN, Gilman RH, Willig MR, Gotuzzo E, Vinetz JM, 2003. Leptospirosis: a zoonotic disease of global. Lancet Infect Dis 3: 757-771.
2. Meites E, Jay MT, Deresinski S, Shieh WJ, Zaki SR, Tompkins L, Smith DS, 2004. Reemerging leptospirosis, California. Emerg Infect Dis 10: 406-412. (Pubitemid 38314464)
3. Tangkanakul W, Tharmaphornpil P, Plikaytis BD, Bragg S, Poonsuksombat D, Choomkasien P, Kingnate D, Ashford DA, 2000. Risk factors associated with leptospirosis in northeastern Thailand. Am J Trop Med Hyg 63: 204-208. (Pubitemid 32488361)
4. Vijayachari P, Sugunan AP, Shriram AN, 2008. Leptospirosis: an emerging global public health problem. J Biosci 33: 557-569.
5. Griffith ME, Hospenthal DR, Murray CK, 2006. Antimicrobial therapy of leptospirosis. Curr Opin Infect Dis 19: 533-537. (Pubitemid 44665458)
6. World Health Organization, 2003. Human Leptospirosis: Guidance for Diagnosis, Surveillance and Control. Geneva, Switzerland: World Health Organization.
7. Panaphut T, Domrongkitchaiporn S, Vibhagool A, Thinkamrop B, Susaengrat W, 2003. Ceftriaxone compared with sodium penicillin G for treatment of severe leptospirosis. Clin Infect Dis 36: 1507-1513. (Pubitemid 36783331)
8. Phimda K, Hoontrakul S, Suttinont C, Chareonwat S, Losuwanaluk K, Chueasuwanchai S, Chierakul W, Suwancharoen D, Silpasakorn S, Saisongkorh W, Peacock SJ, Day NP, Suputtamongkol Y, 2007. Doxycycline versus azithromycin for treatment of leptospirosis and scrub typhus. Antimicrob Agents Chemother 51: 3259-3263. (Pubitemid 350067538)
9. Suputtamongkol Y, Niwattayakul K, Suttinont C, Losuwanaluk K, Limpaiboon R, Chierakul W, Wuthiekanun V, Triengrim S, Chenchittikul M, White NJ, 2004. An open, randomized controlled trial of penicillin, doxycycline, and cefotaxime for patients with severe leptospirosis. Clin Infect Dis 39: 1417-1424. (Pubitemid 39518201)
10. Yoshimori RN, Goldberg HS, Blenden DC, 1965. Cephalothin in the treatment of experimental leptospirosis in hamsters. Antimicrob Agents Chemother 5: 450-452.
11. Alexander AD, Rule PL, 1986. Penicillins, cephalosporins, and tetracyclines in treatment of hamsters with fatal leptospirosis. Antimicrob Agents Chemother 30: 835-839. (Pubitemid 17209133)
12. Murray CK, Hospenthal DR, 2004. Broth microdilution susceptibility testing for Leptospira spp. Antimicrob Agents Chemother 48: 1548-1552. (Pubitemid 38544358)
13. Murray CK, Hospenthal DR, 2004. Determination of susceptibilities of 26 Leptospira sp. serovars to 24 antimicrobial agents by broth microdilution technique. Antimicrob Agents Chemother 48: 4002-4005. (Pubitemid 39304634)
14. Ressner RA, Griffith ME, Beckius ML, Pimentel G, Miller RS, Mende K, Fraser SL, Galloway RL, Hospenthal DR, Murray CK, 2008. Antimicrobial susceptibilities of geographically diverse clinical human isolates of Leptospira. Antimicrob Agents Chemother 52: 2750-2754.
15. Griffith ME, Moon JE, Johnson EN, Clark KP, Hawley JS, Hospenthal DR, Murray CK, 2007. Efficacy of fluoroquinolones against Leptospira interrogans in a hamster model. Antimicrob Agents Chemother 51: 2615-2617. (Pubitemid 47047349)
16. Moon JE, Ellis MW, Griffith ME, Hawley JS, Rivard RG, McCall S, Hospenthal DR, Murray CK, 2006. Efficacy of macrolides and telithromycin against leptospirosis in a hamster model. Antimicrob Agents Chemother 50: 1989-1992. (Pubitemid 43807516)
17. Moon JE, Rivard RG, Griffith ME, Ressner RA, McCall S, Reitstetter RE, Hospenthal DR, Murray CK, 2007. Effect of timing and duration of azithromycin therapy of leptospirosis in a hamster model. J Antimicrob Chemother 59: 148-151. (Pubitemid 46017919)
18. Alt DP, Bolin CA, 1996. Preliminary evaluation of antimicrobial agents for treatment of Leptospira interrogans serovar pomona infection in hamsters and swine. Am J Vet Res 57: 59-62. (Pubitemid 26046409)
19. Alt DP, Zuerner RL, Bolin CA, 2001. Evaluation of antibiotics for treatment of cattle infected with Leptospira borgpetersenii serovar hardjo. J Am Vet Med Assoc 219: 636-639. (Pubitemid 32801511)
20. Kirby WMM, Regamey C, 1973. Pharmacokinetics of cefazolin compared with four other cephalosporins. J Infect Dis 128: S341-S345.
21. Clinical and Laboratory Standards Institute, 2008. Performance Standards for Antimicrobial Susceptibility Testing; Eighteenth Informational Supplement. CLSI Document M100-S18. Wayne, PA: Clinical and Laboratory Standards Institute.
22. Levison ME, Johnson WD, Thornhill TS, Kaye D, 1969. Clinical and in vitro evaluation of cephalexin. JAMA 209: 1331-1336.